For instance, lower-expressed THBS2 is related to the poor prognosis of patients with gastric cancer [21], cervical cancer [22], and ovarian cancer [23], while overexpressed THBS2 is related to the poor prognosis of patients with prostate cancer [24], lung cancer [25], and oral cancer [26]. This evidence concerns the gene THBS2 and prostate cancer.